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INTRODUCTION
Laparoscopic surgery requires intra-abdominal carbon diox-
ide (CO2) insufflation with pressures commonly maintained at 
10–15 mm Hg. This state of CO2 pneumoperitoneum and en-
suing reperfusion injury upon deflation is known to cause a de-
crease in splanchnic blood flow and possible organ ischemia 
due to oxidative stress.1-5 Although well-tolerated by most pa-
tients for even an extended period of time, this form of isch-
emia-reperfusion injury and oxidative stress has been recog-
nized as a potentially serious problem in the elderly and parti-
cularly those with multiple comorbidities.1
In order to minimize such injury after laparoscopic surgery, 
many efforts have been made to uncover the underlying me-
chanism of oxidative stress caused by pneumoperitoneum. 
Among the many factors that have been proposed to contrib-
ute to oxidative stress, the decreased bioactivity of nitric oxide 
(NO) has recently received much attention. NO is known to act 
as a vasodilator and to have antithrombotic, anti-inflammato-
ry, anti-proliferative, and antioxidant properties, and it is pro-
duced by three isoforms of NO synthase (NOS): neuronal NOS 
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(nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS).6 
Inclusion of an NO donor substance in the insufflation gas 
was found to be effective in reducing hepatic and renal isch-
emia,7,8 and pretreatment with nitroglycerine also ameliorated 
the adverse renal effects due to CO2 pneumoperitoneum.2,9 
On the other hand, pretreatment with NG-nitro-L-arginine 
methyl ester (L-NAME), an inhibitor of NOS, was shown to 
aggravate renal ischemia.2,10 
Another factor that may be involved in changes of NO syn-
thesis during laparoscopic surgery is the enzyme arginase. 
Given that both NOS and arginase share L-arginine as a sub-
strate, arginase is thought to inhibit NO synthesis by compet-
ing with NOS for L-arginine.11,12 Understandably, the inhibition 
of arginase has been shown to stimulate NO synthesis, while 
overexpression of arginase suppresses NO generation in en-
dothelial cells.11 Arginase exists as either arginase I (Arg I) or ar-
ginase II (Arg II), and both have been reported to be associated 
with endothelial dysfunction and decreased NO, likely by regu-
lating substrate availability.13-15 In this context, the decreased 
bioactivity of NO during pneumoperitoneum can be hypothe-
sized to be related to the relative up-regulation of arginase. 
Although the relationship between decreased NO and spla-
nchnic ischemia during CO2 pneumoperitoneum has been 
studied and supported by several recent studies, the changes 
in specific NOS isoforms have not been elucidated. While eNOS 
is the predominant isoform in the vasculature and is respon-
sible for most of the NO produced in this tissue,16 iNOS is up-
regulated in macrophages and virtually any cell or tissue dur-
ing various inflammatory diseases.6 Furthermore, the role of 
arginase and its reciprocal interactions with NOS during pneu-
moperitoneum is a new area of interest, and arginase may serve 
as a novel target for reducing oxidative stress due to laparo-
scopic surgery. This study was performed to investigate the ex-
pression and activity of the different isoforms of NOS and argi-
nase as well as the changes in NO and degree of oxidative stress 
during CO2 pneumoperitoneum in rats. The concentration of 
proinflammatory cytokines interleukin (IL)-1β, IL-6, and tu-
mor necrosis factor (TNF)-α in the lungs were analyzed to as-
sess the degree of stress response and tissue trauma due to CO2 
pneumoperitoneum, while local oxidative stress in the lung 
tissue was evaluated by examining histopathological changes.
MATERIALS AND METHODS
Animals and experimental design
All procedures of this study were approved by the Yonsei Uni-
versity Institutional Animal Care and Use Committee. Experi-
ments were performed on 30 male Sprague-Dawley rats that 
were 3–4 months old and weighing 250–320 g. The rats were 
allowed to adjust to the controlled laboratory environment of 
22–24°C for at least 7 days with free access to standard labora-
tory chow and tap water prior to experiments. After the rats 
were anesthetized with 2.0% sevoflurane inhalation in the su-
pine position, they were safely secured on a thermoregulated 
pad (37°C) and mechanically ventilated with a volume-driven 
small-animal ventilator (model 665A, Harvard Apparatus, 
Holliston, MA, USA) after tracheotomy. Tidal volume was set 
between 0.5 and 1 mL/100 g of body weight, and the respira-
tory rate was adjusted to 55–60 breaths/min to maintain end-
tidal CO2 at 30–35 mm Hg. Anesthesia was maintained with 
1.5–2.0% sevoflurane with 50% oxygen in air throughout the 
study. The abdominal cavities of the rats were then punctured 
with a Veress needle that was connected to an electronic lapa-
roflator for CO2 insufflation, and the rats were randomized to 
three groups of 10 animals each. The intra-abdominal pres-
sures (IAPs) of the rats in groups IAP-10 and IAP-20 were main-
tained at 10 mm Hg and 20 mm Hg, respectively, for 2 hours, 
while the rats of group IAP-0 were not insufflated with CO2. 
Blood samples were collected 1 hour after abdominal deflation. 
The rats were then euthanized by exsanguination and the aor-
ta and lung tissue were harvested and dissected from connec-
tive tissue in Kreb’s solution. 
Nitrite and malondialdehyde analysis 
Nitrite (NO2-) is a stable metabolite of NO and the most suitable 
and practical method to assess NO synthesis in vivo. Blood 
was collected in tubes using citrate and ethylenediaminetet-
raacetic acid (EDTA) as an anticoagulant and was centrifuged 
for 15 minutes at 1000 g. To measure nitrite, plasma was incu-
bated with 100 μL of Griess reagent [1% sulfanilamide in 0.1 
mol/L HCl and 0.1% N-(1-naphthyl) ethylenediamine dihy-
drochloride, Sigma-Aldrich, Saint Louis, MO, USA] at room 
temperature for 10 minutes. Absorbance was then measured at 
540 nm using a microplate reader. The nitrite content was cal-
culated based on a standard curve constructed with NaNO2.
Malondialdehyde (MDA) is a stable product of lipid peroxi-
dation, which is regarded as an index of oxygen free-radical 
production. Aorta tissue MDA was analyzed using an OxiSe-
lectTM MDA Adduct enzyme-linked immunosorbent assay 
(ELISA) kit (Cell Biolabs, Inc., San Diego, CA, USA). Absor-
bance was read by a microplate reader using 450 nm as the 
primary wave length after adding stop solution to stop the en-
zyme reaction.
Western blot analysis
Aorta and lung tissue were homogenized in ice-cold Proprep 
(Intron Biotechnology, Seongnam, Korea). The expressions of 
eNOS, Arg I, and Arg II were analyzed with aorta tissue, and 
iNOS expression was analyzed with lung tissue. Tissue ex-
tracts were loaded on 8–10% sodium dodecyl sulfate (SDS)-
polyacrylamide gel, and the proteins were transferred on 
polyvinyl-difluoride membranes (0.2 μm: Immun-Blot, Bio-
Rad, Hercules, CA, USA). Membranes were blocked using 5% 
(wt/vol) nonfat milk in Tris-buffered saline with 0.1% 
Tween-20. The blots were incubated overnight at 4°C with pri-
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mary antibodies, eNOS (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), iNOS (Santa Cruz Biotechnology, Santa Cruz, 
CA, USA), Arg I (R&D Systems, Minneapolis, MN, USA), and 
Arg II (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 
1:1000 dilution. After incubation, the membranes were incu-
bated with anti-rabbit, anti-sheep, or anti-mouse secondary 
antibodies at 1:5000 dilution. Protein expression was normal-
ized to β-actin (1:1000 dilution). The bands were detected us-
ing a chemiluminescence assay (ECL Plus, Amersham Biosci-
ences, Sunnyvale, CA, USA). 
Endothelial nitric oxide synthase, inducible nitric 
oxide synthase, and arginase activity
The activities of eNOS and iNOS were assayed by rat ELISA 
kits (Wuhan EIAab Science Co., Ltd., Wuhan, China) with aor-
ta and lung tissue, respectively. In brief, the supernatants of 
aorta and lung tissue were homogenized in ice-cold Proprep, 
and then incubated in a 96-well plate containing the co-fac-
tors and substrate L-arginine for 1 hour at 37°C. After the in-
cubation period, the enzyme-substrate reaction was termi-
nated by the addition of stop solution, and the color change 
was measured spectrophotometrically at wave lengths of 530 
nm and 450 nm for eNOS and iNOS, respectively. 
Activity of intracellular arginase was determined using aor-
ta digest cell lysates with the QuantiChromTM Arginase Assay 
Kit (BioAssay Systems, Hayward, CA, USA), which measured 
the conversion of arginine to urea by arginase. After total pro-
tein quantification, the sample was incubated with arginine 
buffer at 37°C for 2 hours. Optical density was read using a 
430-nm filter.
Proinflammatory cytokine analysis
IL-1β, IL-6, and TNF-α concentrations in the rat lungs were 
measured by ELISA, using kits for the measurement of rat IL-
1β (eBioscience, San Diego, CA, USA), IL-6 (Young In Frontier 
Co., Ltd., Seoul, Korea), and TNF-α (BD Biosciences, San Jose, 
CA, USA). In brief, supernatants of lung tissue were added to 
a 96-well plate coated with corresponding antibodies to each 
cytokine and incubated. Streptavidin-horseradish peroxidase 
conjugate was added as an antibody to a second epitope on 
each cytokine. Absorbance was read using a microplate read-
er with 450 nm as the primary wave length after adding the 
stop solution.
 
Histopathological change assessment in lung tissue 
The lungs of the rats were removed by median sternotomy, 
fixed with 10% paraformaldehyde through trachea infusion, 
and embedded with paraffin. Hematoxylin and eosin (H&E) 
staining was conducted using 4-μm tissue slides. Lung injury 
was assessed according to the modified scoring system de-
scribed by Kristof, et al.17 In brief, two pulmonologists ran-
domly selected ten fields of lung sections from three lobes of 
lung tissue for each rat and used a microscope at 200× magni-
fication to read and score the damaged levels in these sections 
according to the extent of interstitial cellular infiltration, alve-
olar protein exudation, and tissue hemorrhage. A separate 
grade from 0 to 3 was calculated for each field, depending on 
its presence or absence. The sum of each category from 10 dif-
ferent microscopic fields was recorded as the final damaged 
score for each rat. The total lung injury score for each rat was 
determined as the sum of three individual scores for alveolar 
cellularity, protein exudation, and tissue hemorrhage. If the 
interpretations of the two physicians differed significantly, the 
slides were checked by a pathologist.
Statistical analysis
Data are described as mean±SD or numbers of subjects. Non-
parametric data such as proportion of muscular pulmonary 
arteries were analyzed using the chi-square test. An ANOVA 
with Tukey’s multiple comparison was performed to compare 
parametric variables among the three groups. p values less 
than 0.05 were considered statistically significant.
Fig. 1. Effect of CO2 pneumoperitoneum at different IAPs on plasma nitrite and tissue MDA concentrations. (A) Plasma nitrite levels were significantly 
lower in groups IAP-10 and IAP-20 than in group IAP-0. There was no difference between groups IAP-10 and IAP-20. (B) MDA levels were signifi-
cantly higher in group IAP-20 than in groups IAP-0 and IAP-10. There was no difference between groups IAP-0 and IAP-10. *p<0.01, **p<0.001. MDA, 
malondialdehyde; IAP, intra-abdominal pressure.
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RESULTS
Nitrite and malondialdehyde levels
Plasma nitrite levels were significantly lower in rats of groups 
IAP-10 and IAP-20 than in group IAP-0 (8.43±2.09 μmol/mL 
and 8.70±2.90 μmol/mL vs. 13.70±3.20 μmol/mL, respective-
ly; p<0.01 for both). Plasma nitrite was highest in group IAP-0 
among all groups, while there was no difference between gro-
ups IAP-10 and IAP-20 (Fig. 1A). 
MDA levels were significantly higher in group IAP-20 than 
in groups IAP-0 and IAP-10 (1.41±0.17 pmol/mg vs. 1.11±0.09 
pmol/mg and 1.21±0.08 pmol/mg, respectively; p<0.001 and 
p<0.01, respectively). However, there was no difference in 
MDA levels between groups IAP-0 and IAP-10 (Fig. 1B).
Fig. 2. Effect of CO2 pneumoperitoneum at different IAPs on eNOS, iNOS, Arg I, and Arg II protein expression. (A) Western blot for eNOS, iNOS, Arg I, 
Arg II, and β-actin (internal reference) in rat aorta tissue after different intra-abdominal pressures. (B) The expression of eNOS was significantly more 
suppressed in groups IAP-10 and IAP-20 than in group IAP-0, while there was no difference between groups IAP-10 and IAP-20. (C) There were no 
significant differences in iNOS expression among the three groups. (D) There were no significant differences in Arg I expression among the three 
groups. (E) Arg II expression was significantly higher in group IAP-20 than in group IAP-0. *p<0.05, **p<0.01. IAP, intra-abdominal pressure; NOS, ni-
tric oxide synthase; eNOS, endothelial NOS; iNOS, inducible NOS; Arg, arginase.
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Endothelial nitric oxide synthase, inducible nitric 
oxide synthase, arginase I, and arginase II expression
Representative results of Western blot analysis are shown in 
Fig. 2A. The expression of eNOS was significantly more sup-
pressed in groups IAP-10 and IAP-20 than in group IAP-0 
(1.30±0.10 and 0.90±0.27 vs. 1.83±0.21, respectively; p<0.05 
and p<0.01, respectively); however, there was no difference 
between groups IAP-10 and IAP-20 (Fig. 2B). The expression of 
iNOS was found to be comparable between the three groups 
(3.05±0.88, 2.21±1.10, and 1.96±0.93 in groups IAP-0, IAP-10, 
and IAP-20, respectively) (Fig. 2C). There were no significant 
differences in Arg I expression among the three groups (2.02± 
0.80, 1.34±0.50, and 1.25±0.23 in groups IAP-0, IAP-10, and 
IAP-20, respectively) (Fig. 2D). Arg II expression was signifi-
cantly higher in group IAP-20 than in group IAP-0 (5.03±1.53 vs. 
1.30±0.61; p<0.05); however, there was no difference between 
groups IAP-0 and IAP-10 or IAP-10 and IAP-20 (Fig. 2E).
Endothelial nitric oxide synthase, inducible nitric 
oxide synthase, and arginase activity
The activity of eNOS was significantly lower in groups IAP-10 
and IAP-20 than in group IAP-0 (7.18±1.78 U/L and 5.06±1.49 
U/L vs. 11.88±3.69 U/L, respectively; p<0.05 and p<0.001, re-
spectively), with no difference between groups IAP-10 and 
IAP-20 (Fig. 3A). The activity of iNOS was significantly higher 
in group IAP-20 than in groups IAP-0 and IAP-10 (20.91±4.97 
vs. 6.85±2.16 and 9.68±2.84, respectively; p<0.001 in both) (Fig. 
3B). Arginase activity was significantly higher in group IAP-20 
than in groups IAP-0 and IAP-10 (0.54±0.67 U/L vs. 0.09±0.05 
U/L and 0.09±0.04 U/L, respectively; p<0.05 for both). Howev-
er, there was no significant difference in arginase activity be-
tween groups IAP-0 and IAP-10 (Fig. 3C). 
Interleukin-1β, interleukin-6, and tumor necrosis 
factor-α concentration
IL-1β concentration was significantly higher in group IAP-20 
than in group IAP-0 (11.03±2.40 vs. 4.57±1.26; p<0.01) (Fig. 4A). 
IL-6 concentrations were significantly higher in group IAP-20 
than in groups IAP-0 and IAP-10 (55.16±15.02 vs. 21.20±5.86 
and 34.54±10.38, respectively; p<0.01 and p<0.05, respective-
ly); however, there was no difference between groups IAP-0 
and IAP-10 (Fig. 4B). TNF-α was significantly higher in groups 
IAP-10 and IAP-20 than in group IAP-0 (19.22±6.01 and 22.24± 
5.89 vs. 7.89±3.34, respectively; p<0.05 and p<0.01, respective-
ly), while there was no difference between groups IAP-10 and 
IAP-20 (Fig. 4C). 
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Fig. 3. Effect of CO2 pneumoperitoneum at different IAPs on eNOS, iNOS, and arginase activity. (A) The activity of eNOS was significantly lower in 
groups IAP-10 and IAP-20 than in group IAP-0, with no difference between groups IAP-10 and IAP-20. (B) The activity of iNOS was significantly higher 
in group IAP-20 than in groups IAP-0 and IAP-10. (C) Arginase activity was significantly higher in group IAP-20 than in groups IAP-0 and IAP-10. No 
difference was seen between groups IAP-0 and IAP-10. *p<0.05, **p<0.01, ***p<0.001. IAP, intra-abdominal pressure; NOS, nitric oxide synthase; 
eNOS, endothelial NOS; iNOS, inducible NOS.
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Fig. 4. Effect of CO2 pneumoperitoneum at different IAPs on proinflammatory cytokine concentrations. (A) IL-1β was significantly higher in group IAP-
20 than in group IAP-0. (B) IL-6 was significantly higher in group IAP-20 than in groups IAP-0 and IAP-10; however, there was no difference between 
groups IAP-0 and IAP-10. (C) TNF-α was significantly higher in groups IAP-10 and IAP-20 than in IAP-0, while there was no difference between 
groups IAP-10 and IAP-20. *p<0.05, **p<0.01. IAP, intra-abdominal pressure; IL, interleukin; TNF, tumor necrosis factor.
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Histopathological changes in lung tissue
An analysis of the histopathological scores for rat lung tissue 
from the three groups is shown in Table 1. Total scores of lung 
injury were significantly higher in group IAP-20 than in groups 
IAP-0 and IAP-10 (p<0.001 in both), while there was no differ-
ence between groups IAP-0 and IAP-10 (Fig. 5A). Lung sec-
tions stained with H&E revealed normal structures in the IAP-
0 group (Fig. 5B), while inflammatory cell infiltration with 
protein exudation and alveolus collapse were obvious in the 
IAP-20 group (Fig. 5D). The lung tissue of group IAP-10 did not 
show any significant histopathological changes, with only a 
subtle increase in cellularity (Fig. 5C).
Table 1. The Effect of IAP on Histopathological Scores in CO2 Pneumoperitoneum-Induced Lung Injury in Rats
Cellularity Protein exudation Hemorrhage Total scores
IAP 0 mm Hg 1.3±0.6 0.7±0.4 0.5±0.3 2.5±0.8
IAP 10 mm Hg 1.9±1.3 0.9±0.3 0.6±0.3 3.4±1.5
IAP 20 mm Hg 4.2±1.3*† 3.0±0.9*† 0.9±0.4 8.1±0.5*†
IAP, intra-abdominal pressure.
Data are presented as mean±SD.
*p<0.05 compared with IAP-0, †p<0.05 compared with IAP-10.
Fig. 5. The effects of different IAPs on histopathological changes in CO2 pneumoperitoneum-induced lung injury in rats. (A) Total scores of lung injury 
were significantly higher in group IAP-20 than in groups IAP-0 and IAP-10. (B) Normal lung tissue is seen in the IAP-0 group. (C) A slight increase in 
cellularity (arrows) is seen in the IAP-10 group. (D) Inflammatory cell infiltration (arrows) with protein exudation (asterisks) and alveolus collapse is 
seen in the IAP-20 group. *p<0.001. IAP, intra-abdominal pressure.
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DISCUSSION
The results of this study support the well known increase in ox-
idative stress and ischemia-reperfusion injury caused by lapa-
roscopic surgery and show that the level of plasma NO is de-
creased after 2 hours of CO2 pneumoperitoneum. This drop in 
plasma NO levels seems to be mainly due to the decreased ex-
pression and activity of eNOS, while the increase in iNOS ac-
tivity may be related to increased inflammation and tissue in-
jury. Most importantly, our findings provide novel information 
regarding the increased expression and activity of arginase as 
an underlying mechanism of decreased NO availability dur-
ing laparoscopic surgery. 
The involvement of the NO system and the role of endothe-
lium-derived NO in the changes in renal function after CO2 
pneumoperitoneum were suggested by several recent studies. 
Essentially, blockade of NOS with L-NAME was found to ag-
gravate pneumoperitoneum-induced renal hypoperfusion 
and oliguria, while pretreatment with nitroglycerine attenuat-
ed this effect.2,9 Bishara, et al.18 reported the importance of IAP 
by showing that blockade of the NO system with L-NAME had 
adverse renal effects at high yet not moderate IAPs. Moreover, 
they found in another study that rats with decompensated 
congestive heart failure were more susceptible to the adverse 
renal effects of pneumoperitoneum when pretreated with L-
NAME, implying a higher susceptibility to kidney function de-
terioration in patients with cardiovascular diseases.10 The re-
sults of our study support these previous studies by showing 
actual decreases in the expression and activity of eNOS with 
increasing IAP. This would have resulted in a diminished 
amount of endothelium-derived NO and thus a decrease in 
its anti-inflammatory and antioxidant actions. However, plas-
ma nitrite levels were not found to decrease proportionately 
with IAP but were comparable between groups IAP-10 and 
IAP-20. This seems to reflect the induction of iNOS by an in-
crease in proinflammatory cytokines IL-1β, IL-6, and TNF-α 
and a compensatory increase in NO secretion in response to 
worsening hypoperfusion.19
While the results of the present study show that eNOS and 
iNOS activity changes in opposite directions during CO2 pneu-
moperitoneum, existing evidence related to iNOS has indicat-
ed controversial results. Although Romeo, et al.20 found in-
creased iNOS activity and overexpression of iNOS mRNA after 
1 hour of CO2 pneumoperitoneum, Hajri, et al.21 reported that 
2 hours of CO2 pneumoperitoneum led to the depression of 
iNOS mRNA production in rats. Romeo, et al. suggested a time-
dependent effect, due to which the duration of CO2 pneumo-
peritoneum for 2 hours in the former study may have exhaust-
ed macrophage function and therefore iNOS activity. Further 
studies performed using various lengths of CO2 pneumoperi-
toneum are needed to shed more light on the different roles of 
eNOS and iNOS in oxidative stress caused by laparoscopic 
surgery. 
Arginase has received widespread interest as a promising 
therapeutic target in a wide range of physiological and patho-
physiological conditions, such as vascular disease, pulmonary 
disease, infectious disease, and cancer.22 Moreover, the func-
tional significance of arginase and its relevance with the activ-
ity of NOS was emphasized due to the fact that arginase and 
NOS share L-arginine as a substrate.11 However, while oxida-
tive stress, tissue injury, and reduction in kidney function dur-
ing laparoscopic surgery have been suggested to be closely re-
lated to the NO system in several recent studies,1,9,18 the role of 
arginase during CO2 pneumoperitoneum has remained un-
known. Considering the fact that competition for L-arginine 
supply is intensified under acute and chronic stress condi-
tions,23 arginase may contribute to the shortage of NO bioac-
tivity during laparoscopic surgery. As expected, the results of 
this study showed a significant increase in arginase activity at 
the high insufflation pressure of 20 mm Hg. Arginase exists in 
two isoforms in mammals as Arg I and Arg II, which seem to 
be expressed at different sites to different degrees under vari-
ous pathophysiological conditions. Although there is evidence 
suggesting that the predominant isoform detected in human 
endothelium is Arg II,22 both types are reported to be involved 
in endothelial dysfunction and the downregulation of NO 
synthesis to some extent.13-15 Interestingly, the expression of 
Arg I did not differ among the three groups, while Arg II showed 
a trend of higher expression levels with increasing IAPs in the 
present study. This may implicate a stronger association of 
Arg II than of Arg I with increased arginase activity and im-
paired endothelial NO production during CO2 pneumoperito-
neum, suggesting that Arg II may be a more effective thera-
peutic target for the attenuation of adverse effects of laparo-
scopic surgery. 
CO2 pneumoperitoneum has been reported to induce oxi-
dative stress not only in the intra-abdominal organs but also 
in the lungs. An increase in MDA and oxidatively modified pro-
teins in the lung tissue of rats that underwent laparoscopy with 
CO2 pneumoperitoneum was demonstrated in previous stud-
ies.24,25 Also, CO2 pneumoperitoneum maintained at 15 mm 
Hg for only 30 minutes was found to cause diffuse intra-alveo-
lar hemorrhage, dense congestion, and leukocyte infiltration 
with slight alveolar edema in the lung tissue of rats.26 Although 
NO production through the iNOS isoform has been suggested 
to play a deleterious role in drug-induced lung injury,17,27,28 the 
present study demonstrated the concomitant increase in iNOS 
and lung injury after CO2 pneumoperitoneum for the first 
time. Moreover, concentrations of IL-1β, IL-6, and TNF-α were 
all found to show increasing trends with higher IAPs, with all 
three cytokines significantly higher at 20 mm Hg than at 0 mm 
Hg. This increase in inflammatory cytokines seems be respon-
sible for iNOS induction and, therefore, the increase in sys-
temic inflammation and oxidative stress as well as local dam-
age in the lung tissue. Although the use of laparoscopy has 
been found to lead to less production of biochemical markers 
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of surgical stress than open procedures,29-31 our results indi-
cate that lower pressures should be employed when possible. 
It is noteworthy that splanchnic ischemia due to oxidative 
stress has even been reported in previously healthy patients 
undergoing laparoscopic surgery1 and that it extends to extra-
abdominal organs as well.24 The present study shows that ar-
ginase upregulation is clearly involved with the increased oxi-
dative stress due to CO2 pneumoperitoneum, and this finding 
offers a potential target for treatment and prevention of isch-
emia-reperfusion injury during laparoscopic surgery. Recent-
ly, arginase inhibitors such as 2(S)-amino-6-boronohexanoic 
acid (ABH) or Nω-hydroxy-nor-L-arginine (nor-NOHA) have 
been found to be effective for the treatment of various cardio-
vascular diseases32 and even protection against hepatic33 and 
cardiac34 ischemia-reperfusion injury in experimental and 
clinical studies. Further studies on the application of arginase 
inhibitors in laparoscopic surgery for protection against oxi-
dative stress due to ischemia-reperfusion may yield positive 
results leading to safer surgery in high-risk patients.
This study has several limitations. First, while the results of 
this study clearly show a reciprocal action between NOS and 
arginase during CO2 pneumoperitoneum, uncovering the 
mechanism underlying the exact interaction between the two 
enzymes and their subtypes was beyond the scope of this 
study. The exact role of arginase and its metabolism in the hu-
man body itself is not yet completely understood, and further 
research is needed to elucidate the significance of this enzyme 
in many pathophysiological states, including CO2 pneumo-
peritoneum. Secondly, many other factors that may affect the 
extent of oxidative stress, such as different durations of CO2 
pneumoperitoneum, the nature of the gas used, and the posi-
tion of the patient, were not studied. Due to the experimental 
design of this study, we were not able to evaluate the changes 
in the activity and expression of enzymes or levels of oxidative 
stress in a sequential manner; rather, our evaluation only took 
place at a certain time point. We were also not able to differ-
entiate the metabolic effects of CO2 from the effect of increased 
IAP. A study with subdivided groups is needed to provide 
more information regarding the impact of various factors that 
may lead to different amounts of oxidative stress. Thirdly, this 
study was conducted in healthy rats; therefore, the results 
may not accurately represent the patterns of eNOS, iNOS, or 
arginase expression in humans or diseased conditions. While 
arginase is constitutively expressed in endothelial cells, the 
expression of specific isoforms is known to differ among 
mammalian species.22 Lastly, the expression of iNOS was 
studied only with lung tissue in this study. The main cellular 
source for iNOS during the inflammatory process is thought 
to be macrophages;6 therefore, studying iNOS expression and 
activity in peritoneal macrophages may have offered more in-
sight into its involvement during CO2 pneumoperitoneum.
In conclusion, our study shows that while eNOS activity is 
decreased during CO2 pneumoperitoneum, the activity of 
iNOS is significantly increased. This contributes to the in-
creased oxidative stress and inflammation due to CO2 pneu-
moperitoneum, which is evidenced by the increase in inflam-
matory cytokines and histopathological changes in lung tissue. 
Moreover, our findings demonstrate that arginase expression 
and activity is increased during CO2 pneumoperitoneum, 
which seems to act reciprocally in relation to the NO system. 
These results offer a new potential target for attenuating the 
adverse outcomes of laparoscopic surgery. Studies conducted 
in subjects of diseased states such as congestive heart failure 
or vascular diseases may help to anticipate the possible effec-
tiveness of arginase inhibition during laparoscopic surgery in 
patients at high risk of oxidative stress and its side effects.
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